Get started
Author

Aubrey Melody R Rocimo

Observed names: A. Rocimo, Aubrey M. Rocimo, Aubrey Melody Remigio Rocimo, Aubrey Melody Rocimo, Aubrey Rocimo
ORCID: 0000-0003-3914-8996
Observed ORCID: 0000-0003-3914-8996
OpenAlex ID: A5046895342
Digital literacy as a new determinant of health: A scoping review
2023 · Maria del Pilar Arias López, Bradley A. Ong, et al. · PLOS Digital Health · 527
PDF
Sex Differences in Cardiovascular Outcomes and Cholesterol-Lowering Efficacy of PCSK9 Inhibitors
2023 · Frederick Berro Rivera, Sung Whoy Cha, et al. · JACC Advances · 40
Abstract 9692: Sex Differences in Cardiovascular Outcomes of SGLT-2 Inhibitors in Heart Failure Randomized Controlled Trials: A Systematic Review and Meta-Analysis
2022 · Frederick Rivera, Jem Marie Golbin, et al. · Circulation
Abstract 13703: Sex Differences on Cardiovascular Outcomes of Pcsk9-Inhibitors: A Meta-Analysis
2022 · Frederick B Rivera, Deogracias V De Luna, et al. · Circulation
The way forward against intimate partner violence in the Philippines
2022 · Lea Elora A Conda, Gianica Reena S Monteagudo, et al. · The Lancet Psychiatry
Climate change and haematology: perspectives from the Philippines
2022 · Bradley Ashley G Ong, Aubrey Melody R Rocimo, et al. · The Lancet Haematology
P-135 Capecitabine maintenance chemotherapy in the treatment of metastatic colorectal cancer: A meta-analysis
2022 · B. Ong, A. Rocimo, et al. · Annals of Oncology
Capecitabine Maintenance Chemotherapy in the Treatment of Metastatic Colorectal Cancer: A Meta-Analysis
2022 · Bradley Ashley Gue Ong, Aubrey Melody Remigio Rocimo, et al. · Asian Journal of Oncology
PDF
Works count: 8
Citation count: 567
H-index: 2
I10-index: 2
Year
Topic
Type